Endra Life Sciences INC. (NDRA) — 10-Q Filings

10-Q Filings (6)

• ENDRA's Losses Narrow, Cash Dwindles Amid Crypto Pivot — Nov 14, 2025 Risk: high
  ENDRA Life Sciences Inc. reported a net loss of $1,595,959 for the three months ended September 30, 2025, a significant improvement from the $2,354,090 net loss
• ENDRA Narrows Q2 Loss Amidst Deep Cost Cuts, Cash Dwindles — Aug 14, 2025 Risk: high
  ENDRA Life Sciences Inc. reported a net loss of $1,225,912 for the three months ended June 30, 2025, a significant improvement from the $2,229,153 net loss in t
• ENDRA Life Sciences Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  ENDRA Life Sciences Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $25,251,790 and total liabilities of $3,000,0
• ENDRA Life Sciences Files Q3 2024 10-Q — Nov 19, 2024 Risk: medium
  ENDRA Life Sciences Inc. filed its 10-Q for the quarterly period ended September 30, 2024. The company, incorporated in Delaware, is based in Ann Arbor, MI, and
• ENDRA Life Sciences Q2 2024 10-Q Filed — Aug 14, 2024 Risk: medium
  ENDRA Life Sciences Inc. filed its Q2 2024 10-Q report on August 14, 2024, detailing financial performance for the period ending June 30, 2024. The company repo
• ENDRA Life Sciences Inc. Files 10-Q for Q1 2024 — May 14, 2024 Risk: medium
  ENDRA Life Sciences Inc. (NDRA) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. ENDRA Life Sciences Inc. filed a 10-Q report for the period ending

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX